Table 2.
Examples of autophagy alteration in degenerating neurites in different neurodegenerative disorders.
| Disease (Organism/animal or cell model) |
Tissues/cells | Effects | Phenotype | Refs |
|---|---|---|---|---|
|
AD | ||||
| Human patients | Neocortex | Undermined. | Autophagosomes and other prelysosomal autophagic vacuoles accumulate in degenerating neurites. |
[14] |
| Hippocampus and inferior temporal cortex |
Undermined. | Enhanced immunoreactivity of Atg12 in tau-immunopositive dystrophic neurites and some neurofibrillary tangles. |
[15] | |
| Hippocampus | Undermined. | APP accumulates in the lysosomal system of the degenerating neurites present in senile plaques. |
[16] | |
| Biopsied brain material | Undermined. | PS1 immunoreactivity is identified in autophagic vacuoles in degenerating neurites. |
[17] | |
| APP, PS/APP transgenetic mice |
Cerebral cortex, hippocampus |
Beneficial. | Autophagosomes and autolysosomes accumulate in degenerating neurites. Recovery of lysosomal proteolysis reverses axonal dystrophy and enhances maturation of accumulated autophagosomes. |
[17, 31, 40, 72] |
| Lysosomal proteolysis inhibition |
Mouse cortical neurons | Beneficial. | Lysosomal dysfunction disrupts axonal transport of degradative organelles and causes Alzheimer-like neurite dystrophy. |
[31] |
|
ALS | ||||
| SOD1 mutant mice | Spinal cord motor neurons |
Harmful. | Autophagic vacuoles accumulated in degenerating axons. Autophagy stimulation accelerates the motor neuron degeneration. |
[11] |
| Human patients | Motor neurons | Undermined. | The autophagy features were also found in close association with the characteristic inclusions of ALS. |
[95] |
|
Epilepsy | ||||
|
Atg7 conditional knockout mice |
Forebrain neurons | Beneficial. | Atg7-deficiency promotes the development of spontaneous seizures. |
[81] |
| Human TSC patients | Brain tissues | Undermined. | Autophagy is suppressed in brains. | [81] |
| HD | ||||
| Human patients | Striatum | Beneficial. | Beclin1-positive inclusion-like deposits accumulate in axon or neuropil of HD samples. However, striatal neurons in normal control brains show diffuse immunoreactivity for Beclin1. |
[20] |
| Hdh140Q/ΔQ mice | Striatum | Beneficial. | LC3 colocalizes with neuropil htt aggregates in the Hdh140Q/ΔQ striatum at 1 and 2 years of age, and such phenomenon is absent in the Hdh140Q/+ striatum. |
[78] |
|
Inherited ataxias | ||||
| Human patients | Cerebral and brainstem | Undermined. | Widespread axonal aggregates, immunopositive for autophagy associated shuttle protein p62, appear in fiber tracts known to undergo neurodegeneration in SCA3 brains. |
[96] |
|
Lurcher mice, atg5 and atg7 conditional knockout mice |
DCN | Tentatively Beneficial. |
Autophagy serves as an early stress response in axonal dystrophy. Atg7 and Atg5 are both required for the maintenance of axonal homeostasis and the prevention of axonal degeneration. |
[8, 25, 97] |
| pcd mutant mice | DCN | Harmful. | Autophagosomes accumulate in Purkinje cell axons. Increased or aberrant mitophagy may contribute to the Purkinje cell degeneration in pcd mice. |
[9] |
|
PD | ||||
| Human patients | SNpc | Beneficial. | LC3 immunoreactivity is detected in a-synuclein-positive Lewy neurites, a neuropathological feature of PD indicative of axonal pathology. |
[18, 19] |
| G2019S LRRK2 mutant mice |
Cerebral cortex, striatum |
Undermined. | Early and late autophagosomes accumulate in axons and synapses in animals with advanced age. |
[57] |
|
Atg7 conditional knockout mice |
Midbrain DA neurons | Beneficial. | Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of a-synuclein and LRRK2 in the brain. |
[79, 80] |
| G2019S LRRK2 overexpression |
Mouse cortical neurons | Harmful. | LRRK2 mutants selectively cause dendrite retraction due to calcium dysregulation and induction of dendritic mitophagy. |
[54,55] |
| G2019S LRRK2 overexpression |
SH-SY5Y cells | Harmful. | Autophagosomes accumulate in neurites. Autophagy inhibition prevents neuritic retraction, whereas autophagy stimulation potentiates LRRK2-induced neuritic shortening. |
[56] |
| MPP+ intoxication | Mouse DA neurons | Undermined. | Neuritic degeneration and autophagy occurs before cell body loss. |
[98] |
|
Prion disease | ||||
| Human patients | Brain tissues obtained from CJD patients |
Undermined. | Autophagosomes appear in the affected synapses. | [27] |
| CJD-infected hamsters or GSS- infected mice |
Parietal cortex, corpus callosum, hippocampus, thalamus, cerebellum, brainstem |
Undermined. | The major target of autophagy is dystrophic neurites, mostly dendrites but also axonal terminals and preterminals. |
[59] |
| Scrapie prion strain infection |
Mouse brain aggregate | Beneficial. | The LC3-II immunoreactivity is seen as deposits scattered throughout the neuropil. |
[99] |
AD, Alzheimer’s disease; ALS, amyotrophic lateral sclerosis; APP, amyloid precursor protein; CJD, Creutzfeldt-Jakob disease; DA, dopamine; DCN, deep cerebellar nuclei; GSS, Gerstmann-Sträussler-Scheinker; HD, Huntington’s disease; Hdh140Q/ΔQ, full-length htt lacking its polyglutamine stretch in a knockin mouse model for HD; htt, huntingtin; LRRK2, leucine rich repeat kinase 2; MPP+, 1-methyl-4-phenylpyridinium ion; pcd, Purkinje cell degeneration; PD, Parkinson’s disease; PS1, presenilin 1; PS/APP, presenilin/amyloid precursor protein; SCA3, spinocerebellar ataxia type 3; SNpc, substantia nigra pars compacta; TSC, tuberous sclerosis complex.